drugset / Trial / NCT01591447
Safety and Efficacy Study of Single-Dose Oral CEM-101 in Patients With Uncomplicated Urogenital Gonorrhea
Non-randomizedParallel-groupOpen-labelTreatment
Summary
To determine the safety and efficacy of a single dose of solithromycin (CEM-101) for the treatment of uncomplicated urogenital gonorrhea.
Timeline
- Start
- 2012-05
- Primary completion
- 2013-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Solithromycin | Other / unclassified | 1000 mg | Oral |
| Subject | Solithromycin | Other / unclassified | 1200 mg | Oral |